Difficulty: Medium
Average Score: 76%
Practice
The nurse is given an order to give the client milrinone (Primacor). For what reason might this drug be ordered?
Correct answer
A
Rationale
Rationale:
Milrinone (Primacor) is a phosphodiesterase inhibitor used primarily for the treatment of congestive heart failure (CHF). It works by increasing the heart's contractility and thus improving cardiac output in patients with CHF. This drug is particularly beneficial in acute decompensated heart failure situations where other interventions have not been successful.
Option A is correct because milrinone is specifically indicated for congestive heart failure. It is important for nurses to understand the rationale behind using milrinone in CHF to ensure appropriate administration and monitoring.
Options B, C, and D are incorrect:
- Option B (For hypertension): Milrinone is not typically used to treat hypertension as its primary action is on improving cardiac function in heart failure, not on reducing blood pressure.
- Option C (For cardiac arrhythmias): Milrinone is not a first-line treatment for cardiac arrhythmias. While it may have some impact on arrhythmias secondary to heart failure, its primary use is not for treating arrhythmias.
- Option D (For bradycardia): Milrinone is not indicated for treating bradycardia. In fact, it can exacerbate bradycardia in some cases due to its inotropic effects on the heart.
Educationally, understanding the specific indications for cardiovascular drugs like milrinone is crucial for nurses to provide safe and effective care to patients with heart failure. Knowing the appropriate use of medications helps nurses advocate for their patients and collaborate effectively with the healthcare team to achieve optimal outcomes.
Milrinone (Primacor) is a phosphodiesterase inhibitor used primarily for the treatment of congestive heart failure (CHF). It works by increasing the heart's contractility and thus improving cardiac output in patients with CHF. This drug is particularly beneficial in acute decompensated heart failure situations where other interventions have not been successful.
Option A is correct because milrinone is specifically indicated for congestive heart failure. It is important for nurses to understand the rationale behind using milrinone in CHF to ensure appropriate administration and monitoring.
Options B, C, and D are incorrect:
- Option B (For hypertension): Milrinone is not typically used to treat hypertension as its primary action is on improving cardiac function in heart failure, not on reducing blood pressure.
- Option C (For cardiac arrhythmias): Milrinone is not a first-line treatment for cardiac arrhythmias. While it may have some impact on arrhythmias secondary to heart failure, its primary use is not for treating arrhythmias.
- Option D (For bradycardia): Milrinone is not indicated for treating bradycardia. In fact, it can exacerbate bradycardia in some cases due to its inotropic effects on the heart.
Educationally, understanding the specific indications for cardiovascular drugs like milrinone is crucial for nurses to provide safe and effective care to patients with heart failure. Knowing the appropriate use of medications helps nurses advocate for their patients and collaborate effectively with the healthcare team to achieve optimal outcomes.